Phreesia’s ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
Phreesia’s ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
Phreesia, a trusted leader in activation and healthcare media, today announced a partnership with DeepIntent, the leading healthcare marketing platform. Phreesia's ProviderConnect audiences are now available in the DeepIntent Audience Marketplace. Instead of broad-reach awareness blasts, ProviderConnect lets teams reach the right clinicians at the right time based on cases they are likely to see in upcoming practice.
ProviderConnect centers on relevance, keeps privacy at the center and draws on real-world care insights across Phreesia’s product ecosystem to help healthcare marketers inform clinicians about new clinical data, safety and treatment options.
"DeepIntent has long shared our view that health information is most useful when it arrives at the right moment," said David Linetsky, President of Phreesia Network Solutions. "Bringing ProviderConnect to their platform makes it simple for brands already on DeepIntent to reach the right providers at the right time."
“Reaching healthcare professionals requires trusted and differentiated data that’s timely and relevant. Our clients want to get in front of providers before patients walk through their office door, not after the treatment decision is made,” said Natalie Mancuso, SVP, Data Partnerships of DeepIntent. “Phreesia’s ProviderConnect Audiences fit perfectly alongside DeepIntent’s other data capabilities, adding a powerful real-time audience solution that helps healthcare marketers deliver more personalized, impactful media to providers.”
ProviderConnect offers turnkey activation through DeepIntent, helping healthcare marketers engage HCPs across digital channels. To learn more, contact your Phreesia or DeepIntent account representative.
About Phreesia
Phreesia is a trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 180 million patient visits in 2025, or 1 in 6 visits across the U.S. This scale allows Phreesia to make a meaningful impact across the healthcare ecosystem. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives operational efficiency and improves healthcare outcomes. For more information, visit phreesia.com.
About DeepIntent
DeepIntent is the leading healthcare marketing platform, purpose-built to help marketers plan, activate, and optimize data-driven campaigns with speed and precision. Trusted by the world’s top healthcare brands and their agencies, DeepIntent uniquely unites media, identity, and real-world clinical data to power privacy-safe, omnichannel marketing across every screen. Backed by patented technology and proven outcomes, DeepIntent’s platform delivers measurable audience quality and script lift at scale. Learn more at www.deepintent.com.
Media
Phreesia: media@phreesia.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260914368514/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
Why This Vanguard ETF Is One of the Best
6 ETFs To Diversify Away From AI
The Best AI Stocks to Buy Now